Current and future diagnostic and treatment strategies for patients with invasive lobular breast cancer

K Van Baelen,T Geukens,M Maetens, V Tjan-Heijnen,C J Lord,S Linn,F-C Bidard, F Richard,W W Yang, R E Steele,S J Pettitt,C Van Ongeval,M De Schepper,E Isnaldi, I Nevelsteen,A Smeets,K Punie, L Voorwerk,H Wildiers,G Floris,A Vincent-Salomon,P W B Derksen,P Neven,E Senkus, E Sawyer,M Kok,C Desmedt

Annals of Oncology（2022）

引用 25|浏览14

暂无评分

摘要

•Dedicated ILC research is needed; ILC represents a small subgroup within clinical trials that is rarely separately analysed.•Advances are needed for ILC diagnosis both at the imaging and pathological levels.•Treatment targets, as per ESCAT, as well as markers of treatment resistance may differ between ILC and NST.

查看译文

关键词

invasive lobular breast cancer,treatment strategies,clinical management,imaging,ESCAT alterations,ongoing trials

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要